What type of study is this?

This is a In Vitro Study study.

P28 Assessment of colistin susceptibility in carbapenem-resistant Klebsiella pneumoniae and Escherichia coli : a comparison of diagnostics MIC-COL and VITEK® 2 AST-XN21 with broth microdilution

View Full Paper

Ask AI

Bookmark

Authors

This analysis assesses colistin resistance in carbapenem-resistant Enterobacterales, indicating reliable diagnostics may guide therapeutic options.

Colistin resistance was found in 31.9% of clinical carbapenem-resistant isolates, highlighting a rising concern.
Broth microdilution served as the reference standard for assessing colistin susceptibility in this evaluation.
Diagnostics MIC-COL showed 100% categorical agreement, outperforming VITEK® 2 AST-XN21 in essential agreement.
High prevalence of resistance underscores the urgent need for improved diagnostics and larger multicenter studies.

Fatih Mehmet Akıllı (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

This analysis assesses colistin resistance in carbapenem-resistant Enterobacterales, indicating reliable diagnostics may guide therapeutic options.

Colistin resistance was found in 31.9% of clinical carbapenem-resistant isolates, highlighting a rising concern.
Broth microdilution served as the reference standard for assessing colistin susceptibility in this evaluation.
Diagnostics MIC-COL showed 100% categorical agreement, outperforming VITEK® 2 AST-XN21 in essential agreement.
High prevalence of resistance underscores the urgent need for improved diagnostics and larger multicenter studies.

Fatih Mehmet Akıllı (2025) studied this question.

View Full Paper

Ask AI

Bookmark